ReadCoor: Dennis Flannelly
Jul 07, 2020
Multi-omic spatial sequencing company ReadCoor has appointed Dennis Flannelly to its board of directors. Flannelly is currently head of precision medicine for US oncology at Merck, known as MSD outside of the US and Canada. Prior to joining Merck, Flannelly served in leadership roles at PerkinElmer, most recently as VP and general manager of the immunodiagnostics business, and previously as VP of maternal-fetal health. Flannelly has also served as global director of clinical marketing for Thermo Fisher Scientific's immunodiagnostics business. He also served as the head of US marketing for Thermo Fisher.